Skip to main content
Clinical Trials/CTRI/2022/07/043628
CTRI/2022/07/043628
Not yet recruiting
Phase 2

A NOVEL ORAL BIOADHESIVE FORMULATION INCORPORATED WITH NANOHYDROXYAPATITE AND ACORUS CALAMUS RHIZOME EXTRACT TOCOMBAT WHITE SPOT LESION- A RANDOMIZED CONTROLLED TRIA

Dr Jerusha T0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: K026- Dental caries on smooth surface
Sponsor
Dr Jerusha T
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Jerusha T

Eligibility Criteria

Inclusion Criteria

  • 1\. Subjects aged 18\-25 years.
  • 2\. Healthy subjects with no other systemic diseases
  • 3\. Individuals undergoing fixed orthodontic treatment

Exclusion Criteria

  • 1\. Subjects with systemic diseases
  • 2\. Individuals under any medication.
  • 3\. Individuals with high caries risk
  • 4\. Periodontally compromised individuals
  • 5\. Individuals unwilling to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials